Aspen Aerogels (ASPN) Cost of Revenue (2013 - 2026)

Aspen Aerogels (ASPN) has 14 years of Cost of Revenue data on file, last reported at $33.6 million in Q1 2026.

• Quarterly Cost of Revenue fell 39.89% year-over-year to $33.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $202.8 million (down 23.86% YoY) and the FY2025 annual result came in at $225.1 million, down 16.57% from the prior year.
• Cost of Revenue retreated to $33.6 million in Q1 2026, from $64.3 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $76.0 million in Q4 2024 to a low of $33.6 million in Q1 2026.
• A 5-year average of $52.1 million and a median of $52.2 million in 2025 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue soared 334858.33% — and 2026, when it plunged 39.89%.
• Tracing ASPN's Cost of Revenue over 5 years: stood at $45.3 million in 2022, then advanced by 20.59% to $54.6 million in 2023, then soared by 39.11% to $76.0 million in 2024, then dropped by 15.39% to $64.3 million in 2025, then tumbled by 47.71% to $33.6 million in 2026.
• The last three Cost of Revenue figures came in at $33.6 million (Q1 2026), $64.3 million (Q4 2025), and $52.2 million (Q3 2025), per Business Quant data.